Skip to main content
SpringerLink
Log in

Chronic PD in Children: Prescription, Management, and Complications

  • Chapter
  • First Online:
Pediatric Kidney Disease

Abstract

The most frequently prescribed chronic dialysis therapy for children with end stage renal disease (ESRD) worldwide is peritoneal dialysis. While there have been improvements in technique and patient survival among pediatric chronic PD patients, mortality for children on dialysis is very high and even higher than for children who receive a kidney transplant. This chapter focuses on the principles involved in developing and monitoring the PD prescription as well as the infectious and non-infectious complications seen in children on chronic PD. Comprehensive care of the pediatric chronic dialysis patient must include tailoring the PD prescription to provide optimal solute and fluid removal, maximizing growth and neurocognitive development, managing anemia, minimizing bone and mineral metabolism disorder and cardiovascular disease, and addressing the psychosocial well-being of the patient and his/her family. ESRD care begins with careful selection of the most appropriate renal replacement therapy and, if PD is selected, placement of an appropriate PD access.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fadrowski JJ, Alexander SR, Warady BA. The demographics of dialysis in children. In: Warady BA, Schaefer F, Alexander SR, editors. Pediatric dialysis. 2nd ed. New York: Springer; 2012. p. 37–51.

    Chapter  Google Scholar 

  2. Watson AR, Hayes WN, Vondrak K, Ariceta G, Schmitt CP, Ekim M, et al. Factors influencing choice of renal replacement therapy in European Paediatric Nephrology Units. Pediatr Nephrol. 2013;28(12):2361–8.

    Article  PubMed  Google Scholar 

  3. Honda M, Warady BA. Long-term peritoneal dialysis and encapsulating peritoneal sclerosis in children. Pediatr Nephrol. 2010;25(1):75–81.

    Article  PubMed  Google Scholar 

  4. McDonald SP, Craig JC, Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350(26):2654–62.

    Article  CAS  PubMed  Google Scholar 

  5. Verrina E, Edefonti A, Gianoglio B, Rinaldi S, Sorino P, Zacchello G, et al. A multicenter experience on patient and technique survival in children on chronic dialysis. Pediatr Nephrol. 2004;19(1):82–90.

    Article  PubMed  Google Scholar 

  6. Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ. Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990–2010. JAMA. 2013;309(18):1921–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. North American Pediatric Renal Trials and Collaborative Studies. NAPRTCS 2011 annual dialysis report. 2011. Available at https://web.emmes.com/study/ped/annlrept/annualrept2011.pdf.

  8. U S Renal Data System, USRDS 2010 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, 2010.

    Google Scholar 

  9. Fischbach M, Stefanidis CJ, Watson AR, European Paediatric Peritoneal Dialysis Working Group. Guidelines by an ad hoc European committee on adequacy of the paediatric peritoneal dialysis prescription. Nephrol Dial Transplant. 2002;17(3):380–5.

    Article  PubMed  Google Scholar 

  10. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for 2006 updates: hemodialysis adequacy, peritoneal dialysis adequacy, vascular access. Am J Kidney Dis. 2006;48 Suppl 1:S1–322. Am J Kidney Dis 2006;48(Supp 1):S1-S322.

    Google Scholar 

  11. Fischbach M, Terzic J, Menouer S, Haraldsson B. Optimal volume prescription for children on peritoneal dialysis. Perit Dial Int. 2000;20(6):603–6.

    CAS  PubMed  Google Scholar 

  12. Fischbach M, Haraldsson B, Helms P, Danner S, Laugel V, Terzic J. The peritoneal membrane: a dynamic dialysis membrane in children. Adv Perit Dial. 2003;19:265–8.

    PubMed  Google Scholar 

  13. Fischbach M, Dheu C, Seuge-Dargnies L, Delobbe JF. Adequacy of peritoneal dialysis in children: consider the membrane for optimal prescription. Perit Dial Int. 2007;27 Suppl 2:S167–70.

    PubMed  Google Scholar 

  14. Ronco C, Brendolan A, La Greca G. The peritoneal dialysis system. Nephrol Dial Transplant. 1998;13 Suppl 6:94–9.

    Article  PubMed  Google Scholar 

  15. Devuyst O, Rippe B. Water transport across the peritoneal membrane. Kidney Int. 2014;85(4):750–8.

    Article  CAS  PubMed  Google Scholar 

  16. Rippe B. Peritoneal physiology. In: Gokal RC, editor. The textbook of peritoneal dialysis. Dordrecht: Kluwer Academic; 1994. p. 68–132.

    Google Scholar 

  17. Davies SJ. Peritoneal solute transport – we know it is important, but what is it? Nephrol Dial Transplant. 2000;15(8):1120–3.

    Article  CAS  PubMed  Google Scholar 

  18. Rippe B, Rosengren BI, Venturoli D. The peritoneal microcirculation in peritoneal dialysis. Microcirculation. 2001;8(5):303–20.

    Article  CAS  PubMed  Google Scholar 

  19. Flessner MF. Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol. 1991;2(2):122–35.

    CAS  PubMed  Google Scholar 

  20. Crone C. Capillary permeability to small solutes. In: Renkin EM, editor. Handbook of physiology, section 2, The cardiovascular system, vol. 4. Washington, DC: American Physiologic Society; 1984. p. 411.

    Google Scholar 

  21. Rippe B, Venturoli D. Simulations of osmotic ultrafiltration failure in CAPD using a serial three-pore membrane/fiber matrix model. Am J Physiol Renal Physiol. 2007;292(3):F1035–43.

    Article  CAS  PubMed  Google Scholar 

  22. Rippe B. A three-pore model of peritoneal transport. Perit Dial Int. 1993;13 Suppl 2:S35–8.

    PubMed  Google Scholar 

  23. Carlsson O, Nielsen S, Zakaria E, Rippe B. In vivo inhibition of transcellular water channels (aquaporin-1) during acute peritoneal dialysis in rats. Am J Physiol. 1996;271(6 Pt 2):H2254–62.

    CAS  PubMed  Google Scholar 

  24. Ni J, Verbavatz JM, Rippe A, Boisde I, Moulin P, Rippe B, et al. Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int. 2006;69(9):1518–25.

    Article  CAS  PubMed  Google Scholar 

  25. Rippe B, Haraldsson B. Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev. 1994;74(1):163–219.

    CAS  PubMed  Google Scholar 

  26. Verrina E. Peritoneal dialysis. In: Avner E, Harmon W, Niaudet P, Yoshikawa N, editors. Pediatric nephrology. 6th ed. Heidelberg: Springer; 2009. p. 1785–816.

    Chapter  Google Scholar 

  27. Fischbach M, Warady BA. Peritoneal dialysis prescription in children: bedside principles for optimal practice. Pediatr Nephrol. 2009;24(9):1633–42; quiz 1640, 1642.

    Article  PubMed  Google Scholar 

  28. Ronco C, Feriani M, Chiaramonte S, Brendolan A, Bragantini L, Conz P, et al. Pathophysiology of ultrafiltration in peritoneal dialysis. Perit Dial Int. 1990;10(2):119–26.

    CAS  PubMed  Google Scholar 

  29. Asghar RB, Davies SJ. Pathways of fluid transport and reabsorption across the peritoneal membrane. Kidney Int. 2008;73(9):1048–53.

    Article  CAS  PubMed  Google Scholar 

  30. Coester AM, Smit W, Struijk DG, Krediet RT. Peritoneal function in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function. NDT Plus. 2009;2(2):104–10.

    PubMed  PubMed Central  Google Scholar 

  31. Fischbach M, Zaloszyc A, Schaefer B, Schmitt CP. Optimizing peritoneal dialysis prescription for volume control: the importance of varying dwell time and dwell volume. Pediatr Nephrol. 2014;29(8):1321–7.

    Article  PubMed  Google Scholar 

  32. Chagnac A, Herskovitz P, Ori Y, Weinstein T, Hirsh J, Katz M, et al. Effect of increased dialysate volume on peritoneal surface area among peritoneal dialysis patients. J Am Soc Nephrol. 2002;13(10):2554–9.

    Article  PubMed  Google Scholar 

  33. Chagnac A, Herskovitz P, Weinstein T, Elyashiv S, Hirsh J, Hammel I, et al. The peritoneal membrane in peritoneal dialysis patients: estimation of its functional surface area by applying stereologic methods to computerized tomography scans. J Am Soc Nephrol. 1999;10(2):342–6.

    CAS  PubMed  Google Scholar 

  34. Fischbach M, Haraldsson B. Dynamic changes of the total pore area available for peritoneal exchange in children. J Am Soc Nephrol. 2001;12(7):1524–9.

    CAS  PubMed  Google Scholar 

  35. Kohaut EC, Waldo FB, Benfield MR. The effect of changes in dialysate volume on glucose and urea equilibration. Perit Dial Int. 1994;14(3):236–9.

    CAS  PubMed  Google Scholar 

  36. Gehan EA, George SL. Estimation of human body surface area from height and weight. Cancer Chemother Rep. 1970;54(4):225–35.

    CAS  PubMed  Google Scholar 

  37. Morgenstern BZ. Equilibration testing: close, but not quite right. Pediatr Nephrol. 1993;7(3):290–1.

    Article  CAS  PubMed  Google Scholar 

  38. Durand PY, Balteau P, Chanliau J, Kessler M. Optimization of fill volumes in automated peritoneal dialysis. Perit Dial Int. 2000;20 Suppl 2:S83–8.

    PubMed  Google Scholar 

  39. Fischbach M, Terzic J, Laugel V, Escande B, Dangelser C, Helmstetter A. Measurement of hydrostatic intraperitoneal pressure: a useful tool for the improvement of dialysis dose prescription. Pediatr Nephrol. 2003;18(10):976–80.

    Article  CAS  PubMed  Google Scholar 

  40. Fischbach M, Terzic J, Menouer S, Bergere V, Ferjani L, Haraldsson B. Impact of fill volume changes on peritoneal dialysis tolerance and effectiveness in children. Adv Perit Dial. 2000;16:321–3.

    CAS  PubMed  Google Scholar 

  41. McIntyre CW. Update on peritoneal dialysis solutions. Kidney Int. 2007;71(6):486–90.

    Article  CAS  PubMed  Google Scholar 

  42. Delarue J, Maingourd C. Acute metabolic effects of dialysis fluids during CAPD. Am J Kidney Dis. 2001;37(1 Suppl 2):S103–7.

    Article  CAS  PubMed  Google Scholar 

  43. Bredie SJ, Bosch FH, Demacker PN, Stalenhoef AF, van Leusen R. Effects of peritoneal dialysis with an overnight icodextrin dwell on parameters of glucose and lipid metabolism. Perit Dial Int. 2001;21(3):275–81.

    CAS  PubMed  Google Scholar 

  44. Burkart J. Poor nutritional status and inflammation. Metabolic consequences of peritoneal dialysis. Semin Dial. 2004;17(6):498–504.

    Article  PubMed  Google Scholar 

  45. Witowski J, Jorres A, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Bender TO, et al. Glucose degradation products in peritoneal dialysis fluids: do they harm? Kidney Int Suppl. 2003;84:S148–51.

    Article  CAS  Google Scholar 

  46. Pischetsrieder M. Chemistry of glucose and biochemical pathways of biological interest. Perit Dial Int. 2000;20 Suppl 2:S26–30.

    PubMed  Google Scholar 

  47. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, et al. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int. 1997;51(1):182–6.

    Article  CAS  PubMed  Google Scholar 

  48. Yoshino A, Honda M, Fukuda M, Araki Y, Hataya H, Sakazume S, et al. Changes in peritoneal equilibration test values during long-term peritoneal dialysis in peritonitis-free children. Perit Dial Int. 2001;21(2):180–5.

    CAS  PubMed  Google Scholar 

  49. Schmitt CP, Bakkaloglu SA, Klaus G, Schroder C, Fischbach M, European Pediatric Dialysis Working Group. Solutions for peritoneal dialysis in children: recommendations by the European Pediatric Dialysis Working Group. Pediatr Nephrol. 2011;26(7):1137–47.

    Article  PubMed  Google Scholar 

  50. Rusthoven E, Krediet RT, Willems HL, Monnens LA, Schroder CH. Sodium sieving in children. Perit Dial Int. 2005;25 Suppl 3:S141–2.

    CAS  PubMed  Google Scholar 

  51. de Boer AW, Schroder CH, van Vliet R, Willems JL, Monnens LA. Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism. Pediatr Nephrol. 2000;15(1–2):21–4.

    Article  PubMed  Google Scholar 

  52. Michallat AC, Dheu C, Loichot C, Danner S, Fischbach M. Long daytime exchange in children on continuous cycling peritoneal dialysis: preservation of drained volume because of icodextrin use. Adv Perit Dial. 2005;21:195–9.

    CAS  PubMed  Google Scholar 

  53. Venturoli D, Jeloka TK, Ersoy FF, Rippe B, Oreopoulos DG. The variability in ultrafiltration achieved with icodextrin, possibly explained. Perit Dial Int. 2009;29(4):415–21.

    CAS  PubMed  Google Scholar 

  54. Akonur A, Holmes CJ, Leypoldt JK. Peritoneal residual volume induces variability of ultrafiltration with icodextrin. Perit Dial Int. 2014;34(1):95–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Canepa A, Verrina E, Perfumo F. Use of new peritoneal dialysis solutions in children. Kidney Int Suppl. 2008;108:S137–44. doi(108):S137–44.

    Article  CAS  Google Scholar 

  56. Frampton JE, Plosker GL. Icodextrin: a review of its use in peritoneal dialysis. Drugs. 2003;63(19):2079–105.

    Article  CAS  PubMed  Google Scholar 

  57. Canepa A, Perfumo F, Carrea A, Giallongo F, Verrina E, Cantaluppi A, et al. Long-term effect of amino-acid dialysis solution in children on continuous ambulatory peritoneal dialysis. Pediatr Nephrol. 1991;5(2):215–9.

    Article  CAS  PubMed  Google Scholar 

  58. Hoff CM. In vitro biocompatibility performance of Physioneal. Kidney Int Suppl. 2003;88:S57–74.

    Article  CAS  Google Scholar 

  59. Mactier RA, Sprosen TS, Gokal R, Williams PF, Lindbergh M, Naik RB, et al. Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int. 1998;53(4):1061–7.

    Article  CAS  PubMed  Google Scholar 

  60. Ogata S, Naito T, Yorioka N, Kiribayashi K, Kuratsune M, Kohno N. Effect of lactate and bicarbonate on human peritoneal mesothelial cells, fibroblasts and vascular endothelial cells, and the role of basic fibroblast growth factor. Nephrol Dial Transplant. 2004;19(11):2831–7.

    Article  CAS  PubMed  Google Scholar 

  61. Plum J, Razeghi P, Lordnejad RM, Perniok A, Fleisch M, Fussholler A, et al. Peritoneal dialysis fluids with a physiologic pH based on either lactate or bicarbonate buffer-effects on human mesothelial cells. Am J Kidney Dis. 2001;38(4):867–75.

    Article  CAS  PubMed  Google Scholar 

  62. Passlick-Deetjen J, Lage C. Lactate-buffered and bicarbonate-buffered solutions with less glucose degradation products in a two-chamber system. Perit Dial Int. 2000;20 Suppl 2:S42–7.

    PubMed  Google Scholar 

  63. Hekking LH, Zareie M, Driesprong BA, Faict D, Welten AG, de Greeuw I, et al. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J Am Soc Nephrol. 2001;12(12):2775–86.

    CAS  PubMed  Google Scholar 

  64. Jorres A, Bender TO, Finn A, Witowski J, Frohlich S, Gahl GM, et al. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function. Kidney Int. 1998;54(6):2184–93.

    Article  CAS  PubMed  Google Scholar 

  65. Mortier S, Faict D, Lameire NH, De Vriese AS. Benefits of switching from a conventional to a low-GDP bicarbonate/lactate-buffered dialysis solution in a rat model. Kidney Int. 2005;67(4):1559–65.

    Article  CAS  PubMed  Google Scholar 

  66. Wieczorowska-Tobis K, Brelinska R, Witowski J, Passlick-Deetjen J, Schaub TP, Schilling H, et al. Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products. Perit Dial Int. 2004;24(1):48–57.

    CAS  PubMed  Google Scholar 

  67. Witowski J, Korybalska K, Ksiazek K, Wisniewska-Elnur J, Jorres A, Lage C, et al. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant. 2004;19(4):917–24.

    Article  CAS  PubMed  Google Scholar 

  68. Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, et al. Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int. 2003;63(1):298–305.

    Article  CAS  PubMed  Google Scholar 

  69. Kim SG, Kim S, Hwang YH, Kim K, Oh JE, Chung W, et al. Could solutions low in glucose degradation products preserve residual renal function in incident peritoneal dialysis patients? A 1-year multicenter prospective randomized controlled trial (Balnet Study). Perit Dial Int. 2008;28 Suppl 3:S117–22.

    CAS  PubMed  Google Scholar 

  70. Choi HY, Kim DK, Lee TH, Moon SJ, Han SH, Lee JE, et al. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial. Perit Dial Int. 2008;28(2):174–82.

    CAS  PubMed  Google Scholar 

  71. Schmitt CP, von Heyl D, Rieger S, Arbeiter K, Bonzel KE, Fischbach M, et al. Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content. Nephrol Dial Transplant. 2007;22(7):2038–44.

    Article  CAS  PubMed  Google Scholar 

  72. Schmitt CP, Haraldsson B, Doetschmann R, Zimmering M, Greiner C, Boswald M, et al. Effects of pH-neutral, bicarbonate-buffered dialysis fluid on peritoneal transport kinetics in children. Kidney Int. 2002;61(4):1527–36.

    Article  PubMed  Google Scholar 

  73. Schmitt CP, Nau B, Gemulla G, Bonzel KE, Holtta T, Testa S, et al. Effect of the dialysis fluid buffer on peritoneal membrane function in children. Clin J Am Soc Nephrol. 2013;8(1):108–15.

    Article  CAS  PubMed  Google Scholar 

  74. Rees L, Azocar M, Borzych D, Watson AR, Buscher A, Edefonti A, et al. Growth in very young children undergoing chronic peritoneal dialysis. J Am Soc Nephrol. 2011;22(12):2303–12.

    Article  PubMed  PubMed Central  Google Scholar 

  75. International Pediatric Peritoneal Dialysis Network. Available at http://www.pedpd.org/.

  76. Fischbach M. Peritoneal dialysis prescription for neonates. Perit Dial Int. 1996;16 Suppl 1:S512–4.

    PubMed  Google Scholar 

  77. Nakayama M, Kasai K, Imai H, TRM-280 Study Group. Novel low Na peritoneal dialysis solutions designed to optimize Na gap of effluent: kinetics of Na and water removal. Perit Dial Int. 2009;29(5):528–35.

    CAS  PubMed  Google Scholar 

  78. Davies S, Carlsson O, Simonsen O, Johansson AC, Venturoli D, Ledebo I, et al. The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant. 2009;24(5):1609–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  79. Moe SM, Drueke T. Improving global outcomes in mineral and bone disorders. Clin J Am Soc Nephrol. 2008;3 Suppl 3:S127–30.

    Article  PubMed  PubMed Central  Google Scholar 

  80. National Kidney Foundation. KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. Am J Kidney Dis. 2009;53(3 Suppl 2):S1–124.

    Google Scholar 

  81. Kim DJ, Do JH, Huh W, Kim YG, Oh HY. Dissociation between clearances of small and middle molecules in incremental peritoneal dialysis. Perit Dial Int. 2001;21(5):462–6.

    CAS  PubMed  Google Scholar 

  82. Paniagua R, Ventura Mde J, Rodriguez E, Sil J, Galindo T, Hurtado ME, et al. Impact of fill volume on peritoneal clearances and cytokine appearance in peritoneal dialysis. Perit Dial Int. 2004;24(2):156–62.

    CAS  PubMed  Google Scholar 

  83. Chiu MC, Ng CF, Lee LP, Lai WM, Lau SC. Automated peritoneal dialysis in children and adolescents – benefits: a survey of patients and parents on health-related quality of life. Perit Dial Int. 2007;27 Suppl 2:S138–42.

    PubMed  Google Scholar 

  84. Fabian Velasco R, Lagunas Munoz J, Sanchez Saavedra V, Mena Brito Trejo JE, Qureshi AR, Garcia-Lopez E, et al. Automated peritoneal dialysis as the modality of choice: a single-center, 3-year experience with 458 children in Mexico. Pediatr Nephrol. 2008;23(3):465–71.

    Article  PubMed  Google Scholar 

  85. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, More HL. Peritoneal equilibration test. Perit Dial Bull. 1986;7:138–47.

    Google Scholar 

  86. Twardowski ZJ, Prowant BF, Moore HL, Lou LC, White E, Farris K. Short peritoneal equilibration test: impact of preceding dwell time. Adv Perit Dial. 2003;19:53–8.

    PubMed  Google Scholar 

  87. Smit W. Estimates of peritoneal membrane function – new insights. Nephrol Dial Transplant. 2006;21 Suppl 2:ii16–9.

    CAS  PubMed  Google Scholar 

  88. Fischbach M, Desprez P, Terzic J, Lahlou A, Mengus L, Geisert J. Use of intraperitoneal pressure, ultrafiltration and purification dwell times for individual peritoneal dialysis prescription in children. Clin Nephrol. 1996;46(1):14–6.

    CAS  PubMed  Google Scholar 

  89. Fischbach M, Lahlou A, Eyer D, Desprez P, Geisert J. Determination of individual ultrafiltration time (APEX) and purification phosphate time by peritoneal equilibration test: application to individual peritoneal dialysis modality prescription in children. Perit Dial Int. 1996;16 Suppl 1:S557–60.

    PubMed  Google Scholar 

  90. Fischbach M, Issad B, Dubois V, Taamma R. The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short/long) and fill volume (small/large): a randomized controlled trial. Perit Dial Int. 2011;31(4):450–8.

    Article  PubMed  Google Scholar 

  91. Schmitt CP, Zaloszyc A, Schaefer B, Fischbach M. Peritoneal dialysis tailored to pediatric needs. Int J Nephrol. 2011;2011:940267.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Warady BA, Alexander SR, Hossli S, Vonesh E, Geary D, Watkins S, et al. Peritoneal membrane transport function in children receiving long-term dialysis. J Am Soc Nephrol. 1996;7(11):2385–91.

    CAS  PubMed  Google Scholar 

  93. Schaefer F, Langenbeck D, Heckert KH, Scharer K, Mehls O. Evaluation of peritoneal solute transfer by the peritoneal equilibration test in children. Adv Perit Dial. 1992;8:410–5.

    CAS  PubMed  Google Scholar 

  94. Warady BA, Jennings J. The short PET in pediatrics. Perit Dial Int. 2007;27(4):441–5.

    CAS  PubMed  Google Scholar 

  95. Schaefer F. The PET-iatrics of peritoneal solute transport: is short also good for the young ones? Perit Dial Int. 2007;27(4):413–4.

    PubMed  Google Scholar 

  96. Gruskin AB, Rosenblum H, Baluarte HJ, Morgenstern BZ, Polinsky MS, Perlman SA. Transperitoneal solute movement in children. Kidney Int Suppl. 1983;15:S95–100.

    CAS  PubMed  Google Scholar 

  97. Geary DF, Harvey EA, Balfe JW. Mass transfer area coefficients in children. Perit Dial Int. 1994;14(1):30–3.

    CAS  PubMed  Google Scholar 

  98. Morgenstern BZ, Baluarte HJ. Peritoneal dialysis kinetics in children. In: Fine RN, editor. Chronic Ambulatory Peritoneal Dialysis (CAPD) and Chronic Cycling Peritoneal Dialysis (CCPD) in children. Boston: Martinus Nijhoff; 1987. p. 47–61.

    Chapter  Google Scholar 

  99. Verrina E, Amici G, Perfumo F, Trivelli A, Canepa A, Gusmano R. The use of the PD adequest mathematical model in pediatric patients on chronic peritoneal dialysis. Perit Dial Int. 1998;18(3):322–8.

    CAS  PubMed  Google Scholar 

  100. Warady BA, Watkins SL, Fivush BA, Andreoli SP, Salusky I, Kohaut EC, et al. Validation of PD adequest 2.0 for pediatric dialysis patients. Pediatr Nephrol. 2001;16(3):205–11.

    Article  CAS  PubMed  Google Scholar 

  101. Reddingius RE, Schroder CH, Willems JL, Lelivelt M, Kohler BE, Krediet RT, et al. Measurement of peritoneal fluid handling in children on continuous ambulatory peritoneal dialysis using dextran 70. Nephrol Dial Transplant. 1995;10(6):866–70.

    CAS  PubMed  Google Scholar 

  102. Schaefer F, Haraldsson B, Haas S, Simkova E, Feber J, Mehls O. Estimation of peritoneal mass transport by three-pore model in children. Kidney Int. 1998;54(4):1372–9.

    Article  CAS  PubMed  Google Scholar 

  103. Haraldsson B. Assessing the peritoneal dialysis capacities of individual patients. Kidney Int. 1995;47(4):1187–98.

    Article  CAS  PubMed  Google Scholar 

  104. Van Biesen W, Van der Tol A, Veys N, Dequidt C, Vijt D, Lameire N, et al. The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients. Clin J Am Soc Nephrol. 2006;1(2):269–74.

    Article  PubMed  Google Scholar 

  105. Bouts AH, Davin JC, Groothoff JW, Van Amstel SP, Zweers MM, Krediet RT. Standard peritoneal permeability analysis in children. J Am Soc Nephrol. 2000;11(5):943–50.

    CAS  PubMed  Google Scholar 

  106. Galach M, Antosiewicz S, Baczynski D, Wankowicz Z, Waniewski J. Sequential peritoneal equilibration test: a new method for assessment and modelling of peritoneal transport. Nephrol Dial Transplant. 2013;28(2):447–54.

    Article  CAS  PubMed  Google Scholar 

  107. La Milia V, Di Filippo S, Crepaldi M, Del Vecchio L, Dell’Oro C, Andrulli S, et al. Mini-peritoneal equilibration test: a simple and fast method to assess free water and small solute transport across the peritoneal membrane. Kidney Int. 2005;68(2):840–6.

    Article  PubMed  Google Scholar 

  108. La Milia V, Pozzoni P, Virga G, Crepaldi M, Del Vecchio L, Andrulli S, et al. Peritoneal transport assessment by peritoneal equilibration test with 3.86% glucose: a long-term prospective evaluation. Kidney Int. 2006;69(5):927–33.

    Article  PubMed  CAS  Google Scholar 

  109. II. NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis. 2001;37(1 Suppl):S65–136.

    Google Scholar 

  110. Schaefer F, Klaus G, Mehls O. Peritoneal transport properties and dialysis dose affect growth and nutritional status in children on chronic peritoneal dialysis. Mid-European Pediatric Peritoneal Dialysis Study Group. J Am Soc Nephrol. 1999;10(8):1786–92.

    CAS  PubMed  Google Scholar 

  111. Bakkaloglu SA, Borzych D, Soo Ha I, Serdaroglu E, Buscher R, Salas P, et al. Cardiac geometry in children receiving chronic peritoneal dialysis: findings from the International Pediatric Peritoneal Dialysis Network (IPPN) registry. Clin J Am Soc Nephrol. 2011;6(8):1926–33.

    Article  PubMed  PubMed Central  Google Scholar 

  112. Chadha V, Blowey DL, Warady BA. Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis? Perit Dial Int. 2001;21 Suppl 3:S179–84.

    PubMed  Google Scholar 

  113. Morgenstern BZ, Mahoney DW, Warady BA. Estimating total body water in children on the basis of height and weight: a reevaluation of the formulas of Mellits and Cheek. J Am Soc Nephrol. 2002;13(7):1884–8.

    Article  PubMed  Google Scholar 

  114. Mitsnefes M, Stablein D. Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Kidney Dis. 2005;45(2):309–15.

    Article  PubMed  Google Scholar 

  115. Kramer AM, van Stralen KJ, Jager KJ, Schaefer F, Verrina E, Seeman T, et al. Demographics of blood pressure and hypertension in children on renal replacement therapy in Europe. Kidney Int. 2011;80(10):1092–8.

    Article  PubMed  Google Scholar 

  116. Paniagua R, Ventura MD, Avila-Diaz M, Hinojosa-Heredia H, Mendez-Duran A, Cueto-Manzano A, et al. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant. 2010;25(2):551–7.

    Article  CAS  PubMed  Google Scholar 

  117. Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V. Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant. 2012;27(6):2404–10.

    Article  PubMed  Google Scholar 

  118. Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant. 2009;24(5):1574–9.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Chaudhuri A, Sutherland SM, Begin B, Salsbery K, McCabe L, Potter D, et al. Role of twenty-four-hour ambulatory blood pressure monitoring in children on dialysis. Clin J Am Soc Nephrol. 2011;6(4):870–6.

    Article  PubMed  PubMed Central  Google Scholar 

  120. Wuhl E, Fusch C, Scharer K, Mehls O, Schaefer F. Assessment of total body water in paediatric patients on dialysis. Nephrol Dial Transplant. 1996;11(1):75–80.

    Article  CAS  PubMed  Google Scholar 

  121. Edefonti A, Mastrangelo A, Paglialonga F. Assessment and monitoring of nutrition status in pediatric peritoneal dialysis patients. Perit Dial Int. 2009;29 Suppl 2:S176–9.

    PubMed  Google Scholar 

  122. Woodrow G, Ronco C. Assessment of fluid status in peritoneal dialysis. Contrib Nephrol. 2012;178:164–8.

    Article  PubMed  Google Scholar 

  123. Borzych-Duzalka D, Bilginer Y, Ha IS, Bak M, Rees L, Cano F, et al. Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol. 2013;24:665–76.

    Article  PubMed  PubMed Central  Google Scholar 

  124. Schaefer F, Borzych-Duzalka D, Azocar M, Munarriz RL, Sever L, Aksu N, Barbosa LS, Galan YS, Xu H, Coccia PA, Szabo A, Wong W, Salim R, Vidal E, Pottoore S, Warady BA, IPPN investigators. Impact of global economic disparities on practices and outcomes of chronic peritoneal dialysis in children: insights from the International Pediatric Peritoneal Dialysis Network Registry. Perit Dial Int. 2012;32:399–409.

    Article  PubMed  PubMed Central  Google Scholar 

  125. Benfield MR, McDonald R, Sullivan EK, Stablein DM, Tejani A. The 1997 annual renal transplantation in children: report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant. 1999;2:152–67.

    Article  Google Scholar 

  126. North American Pediatric Renal Trials, Cooperative Studies (NAPRTCS). Annual report. Rockville: EMMES Corporation; 2008. p. 2008.

    Google Scholar 

  127. Schaefer F, Klaus G, Müller-Wiefel DE, Mehls O, Mid European Pediatric Peritoneal Dialysis Study Group (MEPPS). Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. J Am Soc Nephrol. 1999;10:136–45.

    CAS  PubMed  Google Scholar 

  128. Feneberg R, Warady BR, Alexander SR, Schaefer F. The International Pediatric Peritonitis Registry: a global internet-based initiative in pediatric dialysis. Perit Dial Int. 2005;25 Suppl 3:S130–4.

    PubMed  Google Scholar 

  129. Warady BA, Schaefer F, Holloway M, Alexander S, Kandert M, Piraino B, Salusky I, Tranæus A, Divino J, Honda M, Mujais S, Verrina E. Consensus guidelines for the treatment of peritonitis in pediatric patients receiving peritoneal dialysis. Perit Dial Int. 2000;10:610–24.

    Google Scholar 

  130. Warady BA, Bakkaloglu S, Newland J, Cantwell M, Verrina E, Neu A, Chadha V, Yap HK, Schaefer F. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Periton Dial Int. 2012;32 Suppl 2:S32–86.

    Article  CAS  Google Scholar 

  131. Furth SL, Donaldson LA, Sullivan EK, Watkins SL. Peritoneal dialysis catheter infections and peritonitis in children: a report of the North American Pediatric Renal Transplant Cooperative study. Pediatr Nephrol. 2000;15:179–82.

    Article  CAS  PubMed  Google Scholar 

  132. North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Annual Dialysis Report. Rockville: Emmes Corporation; 2011.

    Google Scholar 

  133. Sardegna KM, Beck AM, Strife CF. Evaluation of perioperative antibiotics at the time of dialysis catheter placement. Pediatr Nephrol. 1998;12:149–52.

    Article  CAS  PubMed  Google Scholar 

  134. Hoshii S, Wada N, Honda M, Japanese Study Group of Pediatric Peritoneal Dialysis. A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD. Pediatr Nephrol. 2006;21:828–34.

    Article  PubMed  Google Scholar 

  135. Vychytil A, Lorenz M, Schneider B, et al. New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography. J Am Soc Nephrol. 1998;9:290–6.

    CAS  PubMed  Google Scholar 

  136. Kwan T, Tong M, Siu Y, et al. Ultrasonography in the management of exit site infections in peritoneal dialysis patients. Nephrology. 2004;9:348–52.

    Article  PubMed  Google Scholar 

  137. Yoshino A, Honda M, Ikeda M, et al. Merit of the cuff-shaving procedure in children with chronic infection. Pediatr Nephrol. 2004;19(11):1267–72.

    Article  PubMed  Google Scholar 

  138. Macchini F, Testa S, Valade A, et al. Conservative surgical management of catheter infections in children on peritoneal dialysis. Pediatr Surg Int. 2009;25(8):703–7.

    Article  PubMed  Google Scholar 

  139. Piraino B, Bailie G, Bernardini J, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107–31.

    PubMed  Google Scholar 

  140. Schaefer F, Feneberg R, Aksu N, Donmez O, Sadikoglu B, Alexander SR, Mir S, Ha IS, Fischbach M, Simkova E, Watson AR, Moller K, von Baum H, Warady BA. Worldwide variation of dialysis-associated peritonitis in children. Kidney Int. 2007;72:1374–9.

    Article  CAS  PubMed  Google Scholar 

  141. Lane J, Warady BA, Feneberg R, et al. Relapsing peritonitis in children who undergo chronic peritoneal dialysis: a prospective study of the international pediatric peritonitis registry. Clin J Am Soc Nephrol. 2010;5:1041–6.

    Article  PubMed  PubMed Central  Google Scholar 

  142. Zurowska A, Feneberg R, Warady B, et al. Gram-negative peritonitis in children undergoing long-term peritoneal dialysis. Am J Kidney Dis. 2008;51:455–62.

    Article  PubMed  Google Scholar 

  143. Piraino B. Peritoneal dialysis catheter replacement: “save the patient and not the catheter”. Semin Dial. 2003;16:72–5.

    Article  PubMed  Google Scholar 

  144. Szeto C, Chow K, Wong T, et al. Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal. J Am Soc Nephrol. 2002;13:1040–5.

    PubMed  Google Scholar 

  145. Choi P, Nemati E, Banerjee A, et al. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization. Am J Kidney Dis. 2004;43:103–11.

    Article  PubMed  Google Scholar 

  146. Warady B, Feneberg R, Verrina E, et al. Peritonitis in children who receive long-term dialysis: a prospective evaluation of therapeutic guidelines. J Am Soc Nephrol. 2007;18(7):2172–9.

    Article  PubMed  Google Scholar 

  147. Williams A, Boletis I, Johnson B, et al. Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis. Perit Dial Int. 1989;9(1):65–7.

    CAS  PubMed  Google Scholar 

  148. Klaus G, Schaefer F, Querfeld U, et al. Treatment of relapsing peritonitis in pediatric patients on peritoneal dialysis. Adv Perit Dial. 1992;8:302–5.

    CAS  PubMed  Google Scholar 

  149. Duch J, Yee J. Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. Am J Kidney Dis. 2001;37(1):149–53.

    Article  CAS  PubMed  Google Scholar 

  150. Warady BA, Bashir M, Donaldson LA. Fungal peritonitis in children receiving peritoneal dialysis: a report of the NAPRTCS. Kidney Int. 2000;58(1):384–9.

    Article  CAS  PubMed  Google Scholar 

  151. Miles R, Hawley C, McDonald S, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int. 2009;76:622–8.

    Article  PubMed  Google Scholar 

  152. Robitaille P, Merouani A, Clermont M, Herbert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit Dial Int. 1995;15:77–9.

    CAS  PubMed  Google Scholar 

  153. Restrepo C, Chacon J, Manjarres G. Fungal peritonitis in peritoneal dialysis patients: successful prophylaxis with fluconazole, as demonstrated by prospective randomized control trial. Perit Dial Int. 2010;30:619–25.

    Article  PubMed  Google Scholar 

  154. Chang T, Kim H, Park J, et al. Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center. Perit Dial Int. 2011;31(1):60–6.

    Article  PubMed  Google Scholar 

  155. Matuszkiewica-Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int. 2009;29 Suppl 2:S161–5.

    Google Scholar 

  156. Rinaldi S, Sera F, Verrina E, Edefonti A, Gianoglio B, Perfumo F, et al. Chronic peritoneal dialysis catheters in children: a fifteen-year experience of the Italian Registry of Pediatric Chronic Peritoneal Dialysis. Perit Dial Int. 2004;24(5):481–6.

    PubMed  Google Scholar 

  157. Bakkaloglu SA. Non-infectious complications of peritoneal dialysis in children. In: Warady BA, Schaefer F, Alexander SR, editors. Pediatric dialysis. 2nd ed. New York: Springer; 2012. p. 257–71.

    Chapter  Google Scholar 

  158. Bender FH. Avoiding harm in peritoneal dialysis patients. Adv Chronic Kidney Dis. 2012;19(3):171–8.

    Article  PubMed  Google Scholar 

  159. McCormick BB, Bargman JM. Noninfectious complications of peritoneal dialysis: implications for patient and technique survival. J Am Soc Nephrol. 2007;18(12):3023–5.

    Article  PubMed  Google Scholar 

  160. Saha TC, Singh H. Noninfectious complications of peritoneal dialysis. South Med J. 2007;100(1):54–8.

    Article  PubMed  Google Scholar 

  161. Rahim KA, Seidel K, McDonald RA. Risk factors for catheter-related complications in pediatric peritoneal dialysis. Pediatr Nephrol. 2004;19(9):1021–8.

    Article  PubMed  Google Scholar 

  162. Del Peso G, Bajo MA, Costero O, Hevia C, Gil F, Diaz C, et al. Risk factors for abdominal wall complications in peritoneal dialysis patients. Perit Dial Int. 2003;23(3):249–54.

    PubMed  Google Scholar 

  163. Laakkonen H, Holtta T, Lonnqvist T, Holmberg C, Ronnholm K. Peritoneal dialysis in children under two years of age. Nephrol Dial Transplant. 2008;23(5):1747–53.

    Article  PubMed  Google Scholar 

  164. Holtta TM, Ronnholm KA, Jalanko H, Ala-Houhala M, Antikainen M, Holmberg C. Peritoneal dialysis in children under 5 years of age. Perit Dial Int. 1997;17(6):573–80.

    CAS  PubMed  Google Scholar 

  165. von Lilien T, Salusky IB, Yap HK, Fonkalsrud EW, Fine RN. Hernias: a frequent complication in children treated with continuous peritoneal dialysis. Am J Kidney Dis. 1987;10(5):356–60.

    Article  Google Scholar 

  166. Leblanc M, Ouimet D, Pichette V. Dialysate leaks in peritoneal dialysis. Semin Dial. 2001;14(1):50–4.

    Article  CAS  PubMed  Google Scholar 

  167. Chow KM, Szeto CC, Li PK. Management options for hydrothorax complicating peritoneal dialysis. Semin Dial. 2003;16(5):389–94.

    Article  PubMed  Google Scholar 

  168. Bakkaloglu SA, Ekim M, Tumer N, Gungor A, Yilmaz S. Pleurodesis treatment with tetracycline in peritoneal dialysis-complicated hydrothorax. Pediatr Nephrol. 1999;13(7):637–8.

    CAS  PubMed  Google Scholar 

  169. Hutchinson AJ. Serum magnesium and end-stage renal disease. Perit Dial Int. 1997;17(4):327–9.

    CAS  PubMed  Google Scholar 

  170. Wei M, Esbaei K, Bargman JM, Oreopoulos DG. Inverse correlation between serum magnesium and parathyroid hormone in peritoneal dialysis patients: a contributing factor to adynamic bone disease? Int Urol Nephrol. 2006;38(2):317–22.

    Article  CAS  PubMed  Google Scholar 

  171. Wei M, Esbaei K, Bargman J, Oreopoulos DG. Relationship between serum magnesium, parathyroid hormone, and vascular calcification in patients on dialysis: a literature review. Perit Dial Int. 2006;26(3):366–73.

    CAS  PubMed  Google Scholar 

  172. Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, et al. Dyslipidemia in children with chronic kidney disease. Kidney Int. 2010;78(11):1154–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  173. Wilson AC, Schneider MF, Cox C, Greenbaum LA, Saland J, White CT, et al. Prevalence and correlates of multiple cardiovascular risk factors in children with chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(12):2759–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  174. Mitsnefes MM. Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol. 2012;23(4):578–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  175. Bakkaloglu SA, Ekim M, Tumer N, Soylu K. The effect of CAPD on the lipid profile of pediatric patients. Perit Dial Int. 2000;20(5):568–71.

    CAS  PubMed  Google Scholar 

  176. Bakkaloglu SA, Saygili A, Sever L, Noyan A, Akman S, Ekim M, et al. Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report. Nephrol Dial Transplant. 2009;24(11):3525–32.

    Article  PubMed  Google Scholar 

  177. Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. KDIGO clinical practice guideline for lipid management in chronic kidney disease. Kidney Int Suppl. 2013;3(3):259–305.

    Article  Google Scholar 

  178. Flynn CT, Chandra PKG, Shadur CA. Recurrent pancreatitis in a patient on CAPD. Perit Dial Int. 1986;6(2):102.

    Google Scholar 

  179. Kawaguchi Y, Kawanishi H, Mujais S, Topley N, Oreopoulos DG. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int. 2000;20 Suppl 4:S43–55.

    PubMed  Google Scholar 

  180. Kawanishi H, Kawaguchi Y, Fukui H, Hara S, Imada A, Kubo H, et al. Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. Am J Kidney Dis. 2004;44(4):729–37.

    Article  PubMed  Google Scholar 

  181. Brown MC, Simpson K, Kerssens JJ, Mactier RA, Scottish Renal Registry. Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol. 2009;4(7):1222–9.

    Article  PubMed  PubMed Central  Google Scholar 

  182. Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SL, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2009;24(10):3209–15.

    Article  PubMed  Google Scholar 

  183. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis. 1996;28(3):420–7.

    Article  CAS  PubMed  Google Scholar 

  184. Rigby RJ, Hawley CM. Sclerosing peritonitis: the experience in Australia. Nephrol Dial Transplant. 1998;13(1):154–9.

    Article  CAS  PubMed  Google Scholar 

  185. Summers AM, Clancy MJ, Syed F, Harwood N, Brenchley PE, Augustine T, et al. Single-center experience of encapsulating peritoneal sclerosis in patients on peritoneal dialysis for end-stage renal failure. Kidney Int. 2005;68(5):2381–8.

    Article  PubMed  Google Scholar 

  186. Shroff R, Stefanidis CJ, Askiti V, Edefonti A, Testa S, Ekim M, et al. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group. Nephrol Dial Transplant. 2013;28(7):1908–14.

    Article  CAS  PubMed  Google Scholar 

  187. Braun N, Alscher MD, Kimmel M, Amann K, Buttner M. Encapsulating peritoneal sclerosis – an overview. Nephrol Ther. 2011;7(3):162–71.

    Article  PubMed  Google Scholar 

  188. Hoshii S, Honda M. High incidence of encapsulating peritoneal sclerosis in pediatric patients on peritoneal dialysis longer than 10 years. Perit Dial Int. 2002;22(6):730–1.

    CAS  PubMed  Google Scholar 

  189. Brown EA, Van Biesen W, Finkelstein FO, Hurst H, Johnson DW, Kawanishi H, et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int. 2009;29(6):595–600.

    PubMed  Google Scholar 

  190. Kuriyama S, Tomonari H. Corticosteroid therapy in encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2001;16(6):1304–5.

    Article  CAS  PubMed  Google Scholar 

  191. Rajani R, Smyth J, Koffman CG, Abbs I, Goldsmith DJ. Differential effect of sirolimus vs prednisolone in the treatment of sclerosing encapsulating peritonitis. Nephrol Dial Transplant. 2002;17(12):2278–80.

    Article  CAS  PubMed  Google Scholar 

  192. Lafrance JP, Letourneau I, Ouimet D, Bonnardeaux A, Leblanc M, Mathieu N, et al. Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis. 2008;51(2):e7–10.

    Article  PubMed  Google Scholar 

  193. Latus J, Ulmer C, Fritz P, Rettenmaier B, Biegger D, Lang T, et al. Encapsulating peritoneal sclerosis: a rare, serious but potentially curable complication of peritoneal dialysis-experience of a referral centre in Germany. Nephrol Dial Transplant. 2013;28(4):1021–30.

    Article  PubMed  Google Scholar 

  194. Kawanishi H, Shintaku S, Moriishi M, Dohi K, Tsuchiya S. Seventeen years’ experience of surgical options for encapsulating peritoneal sclerosis. Adv Perit Dial. 2011;27:53–8.

    PubMed  Google Scholar 

  195. Korte MR, Boeschoten EW, Betjes MG, EPS Registry. The Dutch EPS Registry: increasing the knowledge of encapsulating peritoneal sclerosis. Neth J Med. 2009;67(8):359–62.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, The Johns Hopkins University School of Medicine, 200 North Wolfe Street, Rm 3065, Baltimore, MD, 21287, USA

    Alicia M. Neu

  2. Division of Pediatric Nephrology, Heidelberg University Center for Pediatrics and Adolescent Medicine, Im Neuenheimer Feld 430, Heidelberg, 69120, Germany

    Franz Schaefer

Authors
  1. Alicia M. Neu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Franz Schaefer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alicia M. Neu .

Editor information

Editors and Affiliations

  1. Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada

    Denis F. Geary

  2. Division of Pediatric Nephrology, University of Heidelberg, Heidelberg, Germany

    Franz Schaefer

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Neu, A.M., Schaefer, F. (2016). Chronic PD in Children: Prescription, Management, and Complications. In: Geary, D., Schaefer, F. (eds) Pediatric Kidney Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-52972-0_64

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-52972-0_64

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-52970-6

  • Online ISBN: 978-3-662-52972-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation